The Medicines Company announced the appointments of Bruce R. Rosengard and Sanuj K. Ravindran as Vice Presidents, New Business Ventures. Dr. Rosengard is a cardiothoracic surgeon who most recently led the cardiac transplantation team at the Massachusetts General Hospital. Dr. Ravindran is an internist by training who has been focused on healthcare and life science investing since 2003, with particular experience in the Asia Pacific region. Ravindran was most recently a Managing Director at Asian Healthcare Fund.